Antitrust Fears Raised Over Potential Rite Aid Merger

Law360, New York (September 19, 2006, 12:00 AM EDT) -- Concerned over possible antitrust hurdles, a U.S. shareholder activist group has asked Jean Coutu Group Inc. to tackle competition worries regarding the Canadian drugstore chain’s planned sale of its U.S. outlets to Rite Aid Corp.

On Monday, CtW Investment Group sent a letter to Jean Coutu, chairman, president and chief executive officer of the pharmaceutical giant, warning that concerns abound over whether antitrust approval can be secured.

“While the deal appears largely favorable for PJC, anxiety remains around antitrust approval, the same issue that forced Rite...
To view the full article, register now.